Ohki Healthcare Holdings Co.,Ltd. (TYO:3417)
Japan · Delayed Price · Currency is JPY 1,108.00
+2.00 (0.18%)
Jun 19, 2026, 1:06 PM JST
Ohki Healthcare Holdings Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 360,358 | 349,452 | 334,661 | 304,445 | 278,162 | |
Revenue Growth (YoY) | 3.12% | 4.42% | 9.93% | 9.45% | -2.80% |
Cost of Revenue | 342,739 | 330,942 | 317,460 | 288,563 | 264,437 |
Gross Profit | 17,619 | 18,510 | 17,201 | 15,882 | 13,725 |
Selling, General & Admin | 16,523 | 15,408 | 14,811 | 13,496 | 12,745 |
Research & Development | - | 19 | 24 | 24 | 42 |
Operating Expenses | 16,899 | 15,741 | 15,157 | 13,822 | 13,093 |
Operating Income | 720 | 2,769 | 2,044 | 2,060 | 632 |
Interest Expense | -145 | -71 | -35 | -33 | -36 |
Interest & Investment Income | 267 | 222 | 203 | 183 | 185 |
Other Non Operating Income (Expenses) | 1,122 | 1,070 | 1,047 | 943 | 803 |
EBT Excluding Unusual Items | 1,964 | 3,990 | 3,259 | 3,153 | 1,584 |
Gain (Loss) on Sale of Investments | 462 | 13 | 3 | 24 | - |
Gain (Loss) on Sale of Assets | 2 | - | -63 | - | - |
Asset Writedown | -12 | -5 | - | - | - |
Other Unusual Items | -196 | -167 | 206 | 4 | -52 |
Pretax Income | 2,220 | 3,831 | 3,405 | 3,181 | 1,532 |
Income Tax Expense | 941 | 1,188 | 1,278 | 998 | 605 |
Earnings From Continuing Operations | 1,279 | 2,643 | 2,127 | 2,183 | 927 |
Minority Interest in Earnings | 60 | -4 | 83 | -1 | 45 |
Net Income | 1,339 | 2,639 | 2,210 | 2,182 | 972 |
Net Income to Common | 1,339 | 2,639 | 2,210 | 2,182 | 972 |
Net Income Growth | -49.26% | 19.41% | 1.28% | 124.49% | -65.24% |
Shares Outstanding (Basic) | 14 | 14 | 14 | 14 | 14 |
Shares Outstanding (Diluted) | 14 | 14 | 14 | 14 | 14 |
Shares Change (YoY) | - | -0.97% | -0.12% | - | -0.00% |
EPS (Basic) | 98.16 | 193.46 | 160.43 | 158.21 | 70.48 |
EPS (Diluted) | 98.16 | 193.46 | 160.43 | 158.21 | 70.48 |
EPS Growth | -49.26% | 20.59% | 1.40% | 124.49% | -65.24% |
Free Cash Flow | -2,736 | -12,026 | 7,271 | -138 | 1,218 |
Free Cash Flow Per Share | -200.57 | -881.58 | 527.82 | -10.01 | 88.31 |
Dividend Per Share | - | 26.000 | 24.000 | 22.000 | 21.000 |
Dividend Growth | - | 8.33% | 9.09% | 4.76% | 5.00% |
Gross Margin | 4.89% | 5.30% | 5.14% | 5.22% | 4.93% |
Operating Margin | 0.20% | 0.79% | 0.61% | 0.68% | 0.23% |
Profit Margin | 0.37% | 0.76% | 0.66% | 0.72% | 0.35% |
Free Cash Flow Margin | -0.76% | -3.44% | 2.17% | -0.04% | 0.44% |
EBITDA | 1,170 | 3,156 | 2,421 | 2,435 | 1,013 |
EBITDA Margin | 0.33% | 0.90% | 0.72% | 0.80% | 0.36% |
D&A For EBITDA | 450 | 387 | 377 | 375 | 381 |
EBIT | 720 | 2,769 | 2,044 | 2,060 | 632 |
EBIT Margin | 0.20% | 0.79% | 0.61% | 0.68% | 0.23% |
Effective Tax Rate | 42.39% | 31.01% | 37.53% | 31.37% | 39.49% |